GSWM
MDLN

Golden State Wealth Management’s Medline Inc MDLN Stock Holding History

Golden State Wealth Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.89K Hold
200
– – ﹤0.01% 1165
2026
Q1 		$8.9K Hold
200
– – ﹤0.01% 1110
2025
Q4 		$8.4K Buy
+200
New +$8.45K ﹤0.01% 1151

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Golden State Wealth Management's MDLN Position: Q2 2026 in Review

Golden State Wealth Management held its Medline Inc (MDLN) position steady in Q2 2026 at 200 shares worth $7.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Golden State Wealth Management first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.9K in Q1 2026. 230 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Golden State Wealth Management held 200 shares of Medline Inc worth $7.89K as of Q2 2026.
  • Golden State Wealth Management left its Medline Inc share count unchanged in Q2 2026.
  • Medline Inc made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1165 holding.
  • Golden State Wealth Management first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Golden State Wealth Management's Medline Inc position peaked at $8.9K in Q1 2026.
  • 230 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.